Advanced Functional Materials, Journal Year: 2025, Volume and Issue: unknown
Published: May 15, 2025
Abstract cGAS‐STING pathway, an important innate immune signaling has attracted extensive attention in anti‐tumor immunotherapy research. However, the limited delivery ratio of STING agonists and lactate‐induced lactylation present significant challenges advancing antitumor response. Herein, natural anaerobic sulfate‐reducing bacteria (SRB) are utilized as a biofactory to situ biosynthesize MnS nanoparticles (MnS@SRB) for amplifying MnS‐activated responses through continuous lactate depletion by SRB. After intravenous injection, MnS@SRB can actively migrate tumor tissues via SRB‐mediated hypoxia targeting, further continually release H 2 S Mn 2+ acidic microenvironment. stimulates mitochondrial dysfunction induces DNA leakage, which is then recognized cGAS activate pathway. augments STING‐mediated secretion type I interferons inflammatory factors. Importantly, effectively metabolize tumors, thereby alleviating response regulating macrophage phenotype M1‐type, reducing tumor‐infiltrating regulatory T cells increasing CD8 + level, enhancing both adaptive immunosurveillance. As result, inhibite tumors growth metastasis. Therefore, MnS@SRB‐based system enables efficient activator immunosuppressive microenvironment remodeling, opening new avenue synergistically enhanced activation.
Language: Английский